State TX
Clinical Trials in Texas
Recruiting clinical trials with at least one study location in Texas. Data updated daily from ClinicalTrials.gov.
Top Conditions in Texas
NCT07182279 Phase 1, Phase 2
Recruiting
Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patie...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
29 pts
Location
United States
Sponsor
The Methodist Hospital Researc
NCT06999603 Phase 2
Recruiting
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respira...
Condition
Viral Pneumonia
Enrollment
550 pts
Location
United States, Belgium, France
Sponsor
Synairgen Research Ltd.
NCT06006273 Phase 1
Recruiting
A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in ...
Condition
Refractory Solid Tumors
Enrollment
48 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
NCT05318222 N/A
Recruiting
Genetic Inclusion by Virtual Evaluation
Condition
Birth Defects
Enrollment
200 pts
Location
United States
Sponsor
Baylor College of Medicine
NCT06774131 Phase 3
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract...
Condition
Upper Urinary Tract Urothelial Carcinoma
Enrollment
70 pts
Location
United States, Bulgaria, Georgia
Sponsor
UroGen Pharma Ltd.
NCT05349227 N/A
Recruiting
Comprehensive Outcomes for After Cancer Health
Condition
Ovarian Cancer
Enrollment
625 pts
Location
United States
Sponsor
Pack Health
NCT04673942 Phase 2
Recruiting
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
Condition
Solid Tumor, Adult
Enrollment
140 pts
Location
United States
Sponsor
EpicentRx, Inc.
NCT06895070 N/A
Recruiting
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Ac...
Condition
Heart Transplant
Enrollment
60 pts
Location
United States
Sponsor
XVIVO Perfusion
NCT03934905 Phase 1, Phase 2
Recruiting
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Ass...
Condition
Anthracycline Related Cardiotoxicity in Breast Cancer
Enrollment
70 pts
Location
United States
Sponsor
Texas Tech University Health S
NCT06072482 Phase 4
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Condition
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Enrollment
300 pts
Location
United States, Czechia, Hungary
Sponsor
Amgen
NCT07116746 Phase 2
Recruiting
Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase ...
Condition
Gout
Enrollment
25 pts
Location
United States
Sponsor
Arthrosi Therapeutics
NCT06083883 Phase 1
Recruiting
Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Aga...
Condition
Synovial Sarcoma
Enrollment
44 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05541705 N/A
Recruiting
Treadmill Oscillation Walking to Improve Weight Transfer During Gait Following S...
Condition
Treadmill Walking
Enrollment
15 pts
Location
United States
Sponsor
University of Texas at Austin
NCT05952024 Phase 2
Recruiting
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients ...
Condition
Diffuse Large B-Cell Lymphoma
Enrollment
80 pts
Location
United States, Brazil, Puerto Rico
Sponsor
AstraZeneca
NCT07356154 Phase 1, Phase 2
Recruiting
A Study of Revumenib and Mezigdomide in People With Leukemia
Condition
Leukemia
Enrollment
52 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT04864054 Phase 1, Phase 2
Recruiting
T-Cell Therapy (ECT204) in Adults With Advanced HCC
Condition
Hepatocellular Carcinoma
Enrollment
20 pts
Location
United States, Taiwan
Sponsor
Eureka Therapeutics Inc.
NCT07147205 N/A
Recruiting
Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine
Condition
Psychotherapy
Enrollment
72 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06997029 Phase 1
Recruiting
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced ...
Condition
Advanced Solid Tumor
Enrollment
234 pts
Location
United States, Denmark, Japan
Sponsor
Bristol-Myers Squibb
NCT06752668 Phase 2
Recruiting
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Condition
Narcolepsy Type 1
Enrollment
96 pts
Location
United States, Canada
Sponsor
Centessa Pharmaceuticals (UK)
NCT05184569 Phase 1
Recruiting
Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology
Condition
Semantic Dementia
Enrollment
64 pts
Location
United States
Sponsor
Peter Ljubenkov, MD
NCT06795022 Phase 1, Phase 2
Recruiting
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metast...
Condition
Hepatocellular Carcinoma
Enrollment
304 pts
Location
United States, China, Hong Kong
Sponsor
AstraZeneca
NCT00345553 N/A
Recruiting
Biliary Atresia Study in Infants and Children
Condition
Biliary Atresia
Enrollment
1,265 pts
Location
United States, Canada
Sponsor
Arbor Research Collaborative f
NCT06923995 N/A
Recruiting
Expansion and Evaluation of AI-generated Clinical Assessment (AI-COA®) of Depres...
Condition
Depression Disorders
Enrollment
120 pts
Location
United States
Sponsor
Deliberate Solutions Inc.
NCT04870944 Phase 1, Phase 2
Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS ...
Condition
Diffuse Midline Glioma, H3 K27-Altered
Enrollment
63 pts
Location
United States, Australia
Sponsor
Children's Oncology Group